CareDx Revenue 2013-2024 | CDNA
CareDx revenue from 2013 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| CareDx Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $280 |
| 2022 | $322 |
| 2021 | $296 |
| 2020 | $192 |
| 2019 | $127 |
| 2018 | $77 |
| 2017 | $48 |
| 2016 | $41 |
| 2015 | $28 |
| 2014 | $27 |
| 2013 | $22 |
| 2012 | $20 |
| CareDx Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-03-31 | $72 |
| 2023-12-31 | $66 |
| 2023-09-30 | $67 |
| 2023-06-30 | $70 |
| 2023-03-31 | $77 |
| 2022-12-31 | $82 |
| 2022-09-30 | $79 |
| 2022-06-30 | $81 |
| 2022-03-31 | $79 |
| 2021-12-31 | $79 |
| 2021-09-30 | $76 |
| 2021-06-30 | $74 |
| 2021-03-31 | $67 |
| 2020-12-31 | $59 |
| 2020-09-30 | $53 |
| 2020-06-30 | $42 |
| 2020-03-31 | $38 |
| 2019-12-31 | $36 |
| 2019-09-30 | $34 |
| 2019-06-30 | $31 |
| 2019-03-31 | $26 |
| 2018-12-31 | $24 |
| 2018-09-30 | $21 |
| 2018-06-30 | $18 |
| 2018-03-31 | $14 |
| 2017-12-31 | $13 |
| 2017-09-30 | $12 |
| 2017-06-30 | $12 |
| 2017-03-31 | $12 |
| 2016-12-31 | $11 |
| 2016-09-30 | $12 |
| 2016-06-30 | $11 |
| 2016-03-31 | $7 |
| 2015-12-31 | $7 |
| 2015-09-30 | $7 |
| 2015-06-30 | $7 |
| 2015-03-31 | $7 |
| 2014-12-31 | $8 |
| 2014-09-30 | $7 |
| 2014-06-30 | $7 |
| 2014-03-31 | $6 |
| 2013-12-31 | $6 |
| 2013-09-30 | $6 |
| 2013-06-30 | $5 |
| 2013-03-31 | $5 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.811B | $0.280B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $127.319B | 15.98 |
| Cencora (COR) | United States | $43.231B | 16.85 |
| ICON (ICLR) | Ireland | $26.146B | 24.68 |
| DiDi Global (DIDIY) | China | $22.893B | 0.00 |
| Avantor (AVTR) | United States | $16.832B | 24.78 |
| Revvity (RVTY) | United States | $13.903B | 24.39 |
| CochLear (CHEOY) | Australia | $13.785B | 0.00 |
| Natera (NTRA) | United States | $13.325B | 0.00 |
| Viatris (VTRS) | United States | $12.949B | 3.87 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.277B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.078B | 39.74 |
| Charles River Laboratories (CRL) | United States | $11.281B | 21.60 |
| Solventum (SOLV) | United States | $10.689B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.710B | 0.00 |
| HealthEquity (HQY) | United States | $6.914B | 50.94 |
| Organon (OGN) | United States | $5.647B | 5.36 |
| Doximity (DOCS) | United States | $5.229B | 36.40 |
| Bausch + Lomb (BLCO) | Canada | $5.167B | 20.70 |
| PACS (PACS) | United States | $4.153B | 0.00 |
| Life Times (LTH) | United States | $3.281B | 34.38 |
| Surgery Partners (SGRY) | United States | $3.202B | 29.29 |
| Sotera Health (SHC) | United States | $3.185B | 15.62 |
| GoodRx Holdings (GDRX) | United States | $2.701B | 102.86 |
| NovoCure (NVCR) | Jersey | $2.550B | 0.00 |
| Progyny (PGNY) | United States | $2.546B | 43.84 |
| Agilon Health (AGL) | United States | $2.463B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.167B | 8.59 |
| Premier (PINC) | United States | $2.025B | 8.66 |
| Teladoc Health (TDOC) | United States | $2.021B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.967B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.467B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.419B | 0.00 |
| Embecta (EMBC) | United States | $0.783B | 5.32 |
| Auna S.A (AUNA) | Luxembourg | $0.656B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.634B | 6.72 |
| InnovAge Holding (INNV) | United States | $0.619B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.530B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.472B | 47.05 |
| MultiPlan (MPLN) | United States | $0.426B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.418B | 0.00 |
| ModivCare (MODV) | United States | $0.392B | 7.34 |
| LifeMD (LFMD) | United States | $0.329B | 0.00 |
| Beauty Health (SKIN) | United States | $0.326B | 0.00 |
| Sharecare (SHCR) | United States | $0.312B | 0.00 |
| DocGo (DCGO) | United States | $0.306B | 16.72 |
| Sera Prognostics (SERA) | United States | $0.268B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.253B | 0.00 |
| Biodesix (BDSX) | United States | $0.174B | 0.00 |
| So-Young (SY) | China | $0.115B | 38.67 |
| Pono Capital Two (PTWO) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 6.62 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Oncology Institute (TOI) | United States | $0.042B | 0.00 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.015B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |